John G. Conley - 21 Mar 2023 Form 4 Insider Report for IsoPlexis Corp

Role
Director
Signature
/s/ John G. Conley
Issuer symbol
N/A
Transactions as of
21 Mar 2023
Net transactions value
$0
Form type
4
Filing time
21 Mar 2023, 16:46:15 UTC
Previous filing
02 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISO Common Stock Disposed to Issuer -100,752 -100% 0 21 Mar 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISO Stock Option Disposed to Issuer -8,000 -100% 0 21 Mar 2023 Common Stock 8,000 $1.83 Direct F2, F3
transaction ISO Stock Option Disposed to Issuer -40,000 -100% 0 21 Mar 2023 Common Stock 40,000 $10.72 Direct F2, F4
transaction ISO Stock Option Disposed to Issuer -89,047 -100% 0 21 Mar 2023 Common Stock 89,047 $2.10 Direct F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

John G. Conley is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 On March 21, 2023, pursuant to the Agreement and Plan of Merger, dated as of December 21, 2022 (the Merger Agreement), by and among IsoPlexis Corporation, a Delaware corporation (IsoPlexis), Berkeley Lights, Inc., a Delaware corporation (Berkeley Lights), and Iceland Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of Berkeley Lights, each share of common stock, par value $0.001, of IsoPlexis (IsoPlexis Common Stock) reported in this Form 4 was converted into the right to receive 0.6120 fully paid and nonassessable shares of common stock, par value $0.00005, of Berkeley Lights (Berkeley Lights Common Stock), together with cash in lieu of fractional shares of Berkeley Lights Common Stock, if any, and any unpaid dividends or other distributions.
F2 On March 21, 2023, pursuant to the Merger Agreement, each IsoPlexis stock option reported in this Form 4 that was (a) vested and unexercised or (b) vested solely as a result of the consummation of the merger pursuant to the Merger Agreement was, in each case, exercisable prior to the effective time of such merger and, to the extent unexercised at such effective time, canceled for no consideration.
F3 Vested 25% on December 15, 2021 and thereafter in 36 equal monthly installments.
F4 Vested 25% on July 19, 2022 and thereafter in 36 equal monthly installments.
F5 Vests in full on the earlier of June 16, 2023 or the day prior to the next annual stockholders meeting.